156 related articles for article (PubMed ID: 19881512)
1. Hepatitis: new hope for difficult cases of autoimmune hepatitis.
Halac U; Alvarez F
Nat Rev Gastroenterol Hepatol; 2009 Nov; 6(11):629-30. PubMed ID: 19881512
[No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil--a new treatment for autoimmune hepatitis?
Dhawan A; Mieli-Vergani G
J Hepatol; 2000 Sep; 33(3):480-1. PubMed ID: 11020006
[No Abstract] [Full Text] [Related]
3. Use of mycophenolate in the treatment of autoimmune hepatitis.
Oo YH; Neuberger J
Liver Int; 2005 Aug; 25(4):687-91. PubMed ID: 15998416
[No Abstract] [Full Text] [Related]
4. Role of mycophenolate mofetil in the treatment of autoimmune hepatitis.
Schramm C; Lohse AW
J Hepatol; 2011 Sep; 55(3):510-511. PubMed ID: 21281682
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree.
Czaja AJ
J Hepatol; 2009 Jul; 51(1):8-10. PubMed ID: 19446910
[No Abstract] [Full Text] [Related]
6. Use of immunomodulary agents is difficult in treating autoimmune hepatitis patients.
Gordon FD; Simpson M
J Clin Gastroenterol; 2004 Oct; 38(9):729-30. PubMed ID: 15365394
[No Abstract] [Full Text] [Related]
7. [Treatment of autoimmune hepatitis].
Múzes G
Orv Hetil; 2003 Jul; 144(30):1497-8. PubMed ID: 14569681
[No Abstract] [Full Text] [Related]
8. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
Brunt EM; Di Bisceglie AM
Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy.
Devlin SM; Swain MG; Urbanski SJ; Burak KW
Can J Gastroenterol; 2004 May; 18(5):321-6. PubMed ID: 15152283
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
Fallatah HI; Akbar HO
Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
[TBL] [Abstract][Full Text] [Related]
11. [Auto-immune hepatitis: therapeutic management].
Pariente A
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B13-9. PubMed ID: 12843932
[No Abstract] [Full Text] [Related]
12. Drug choices in autoimmune hepatitis: part B--Nonsteroids.
Czaja AJ
Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):617-35. PubMed ID: 23061712
[TBL] [Abstract][Full Text] [Related]
13. Should MMF treatment be the first-line therapy in autoimmune hepatitis?
Alric L
J Hepatol; 2024 Jul; 81(1):e40. PubMed ID: 38403032
[No Abstract] [Full Text] [Related]
14. Use of sirolimus in the treatment of refractory autoimmune hepatitis.
Chatrath H; Allen L; Boyer TD
Am J Med; 2014 Nov; 127(11):1128-1131. PubMed ID: 24979741
[TBL] [Abstract][Full Text] [Related]
15. The use of immunosuppression in autoimmune hepatitis: A current literature review.
Cropley A; Weltman M
Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes.
García-Buey L; Moreno-Otero R
Aliment Pharmacol Ther; 2011 Sep; 34(6):682-4; author reply 684-5. PubMed ID: 21851370
[No Abstract] [Full Text] [Related]
17. Seronegative autoimmune hepatitis presenting after diagnosis of coeliac disease: a case report.
Quail MA; Russell RK; Bellamy C; Mieli-Vergani G; Gillett PM
Eur J Gastroenterol Hepatol; 2009 May; 21(5):576-9. PubMed ID: 19318969
[TBL] [Abstract][Full Text] [Related]
18. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
Baven-Pronk AM; Coenraad MJ; van Buuren HR; de Man RA; van Erpecum KJ; Lamers MM; Drenth JP; van den Berg AP; Beuers UH; den Ouden J; Koek GH; van Nieuwkerk CM; Bouma G; Brouwer JT; van Hoek B
Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459
[TBL] [Abstract][Full Text] [Related]
19. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM
Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421
[TBL] [Abstract][Full Text] [Related]
20. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
Adams B; Lazarchick J; Medina AM; Willner IR; Neville B; Murphy E; Stuart R; Costa LJ
Am J Hematol; 2010 Aug; 85(8):627-9. PubMed ID: 20658594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
